|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | ||
| Functioning Graft at Discharge | 17 | 20 | 16 | 33 | 35 | 47 | 48 | 52 | 61 | 95 | |
| With Immunosuppression Info | 16 | 17 | 16 | 30 | 24 | 45 | 43 | 37 | 46 | 76 | |
| Corticosteroids | Category Usage | 87.5% | 100.0% | 100.0% | 93.3% | 100.0% | 97.8% | 97.7% | 94.6% | 97.8% | 76.3% |
| Prednisone | 87.5% | 100.0% | 81.3% | 70.0% | 83.3% | 73.3% | 79.1% | 56.8% | 73.9% | 43.4% | |
| Methylprednisolone | 0.0% | 5.9% | 31.3% | 30.0% | 16.7% | 24.4% | 18.6% | 37.8% | 26.1% | 32.9% | |
| Cyclosporine | Category Usage | 0.0% | 0.0% | 6.3% | 6.7% | 0.0% | 2.2% | 9.3% | 5.4% | 0.0% | 0.0% |
| Cyclosporin | 0.0% | 0.0% | 6.3% | 6.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Sandimmmune | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.7% | 0.0% | 0.0% | 0.0% | |
| Neoral | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.2% | 4.7% | 5.4% | 0.0% | 0.0% | |
| Tacrolimus | Category Usage | 100.0% | 100.0% | 75.0% | 93.3% | 91.7% | 95.6% | 88.4% | 94.6% | 93.5% | 97.4% |
| FK506 | 100.0% | 100.0% | 75.0% | 93.3% | 91.7% | 95.6% | 88.4% | 94.6% | 93.5% | 97.4% | |
| Antimetabolites | Category Usage | 50.0% | 11.8% | 25.0% | 26.7% | 58.3% | 53.3% | 32.6% | 21.6% | 17.4% | 10.5% |
| Azathioprine | 50.0% | 11.8% | 25.0% | 23.3% | 20.8% | 11.1% | 7.0% | 8.1% | 8.7% | 7.9% | |
| Mycophenolate mofetil | 0.0% | 0.0% | 0.0% | 3.3% | 37.5% | 44.4% | 30.2% | 13.5% | 13.0% | 2.6% | |
| Other | Category Usage | 0.0% | 0.0% | 0.0% | 6.7% | 8.3% | 4.4% | 0.0% | 0.0% | 43.5% | 14.5% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 43.5% | 14.5% | |
| Cytoxan | 0.0% | 0.0% | 0.0% | 6.7% | 8.3% | 4.4% | 0.0% | 0.0% | 0.0% | 0.0% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.